Home / Products / Biosynthesis Chemicals / Enzyme Inhibitors / Proteasome Inhibitors /

Proteasome Inhibitors

Proteasome inhibitors are a class of compounds that have gained significant attention in the field of cancer research and treatment These inhibitors target the proteasome a cellular complex responsible for breaking down proteins in cells By inhibiting this process proteasome inhibitors disrupt the normal protein degradation pathway leading to the accumulation of damaged or misfolded proteins and ultimately triggering cell death This targeted approach has shown promise in the treatment of various types of cancers making proteasome inhibitors a valuable tool in the fight against this devastating disease

Get A Quote
Products Application Supporting Data Resources Related Products


Catalog Number Chemical Name CAS # Price
BC-0682 (-)-Epigallocatechin gallate 989-51-5 Online Inquiry
BC-0693 Celastrol 34157-83-0 Online Inquiry
EI-0165 Amastatin hydrochloride 100938-10-1 Online Inquiry
EI-0494 Calpain Inhibitor I, ALLN 110044-82-1 Online Inquiry
EI-0495 Calpain Inhibitor II, ALLM 136632-32-1 Online Inquiry
EI-0513 Carfilzomib 868540-17-4 Online Inquiry
EI-0555 CEP-18770 847499-27-8 Online Inquiry
EI-0621 Clasto-Lactacystin β-lactone 154226-60-5 Online Inquiry
EI-0624 Clioquinol 130-26-7 Online Inquiry
EI-0821 Epoxomicin 134381-21-8 Online Inquiry
EI-0975 Fenbendazole 43210-67-9 Online Inquiry
EI-1311 Lactacystin (Natural) 133343-34-7 Online Inquiry
EI-1416 Marizomib 437742-34-2 Online Inquiry
EI-1503 MLN-9708 1239908-20-3 Online Inquiry
EI-1641 ONX-0914 960374-59-8 Online Inquiry


Proteasome inhibitors have a wide range of applications in both research and medicine In the field of research they are commonly used to study the role of protein degradation in various biological processes By inhibiting the proteasome scientists can better understand how proteins are regulated and degraded which can provide valuable insights into many diseases and conditions

In medicine proteasome inhibitors are used as a targeted therapy for certain types of cancer By blocking the proteasome's function these inhibitors prevent the breakdown of proteins that control cell growth and division leading to the death of cancer cells This approach has shown significant success in treating multiple myeloma and mantle cell lymphoma and research is ongoing to explore their potential in treating other types of cancer

Additionally proteasome inhibitors are being investigated for their potential in treating autoimmune diseases and neurodegenerative disorders By selectively degrading specific proteins involved in these conditions proteasome inhibitors have the potential to slow or halt disease progression and alleviate symptoms

Overall proteasome inhibitors have emerged as a valuable tool in both research and medicine with the potential to make significant contributions to our understanding and treatment of various diseases

Supporting Data


Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.


There is no product in your cart.